Takashi Nakamura

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 10

Top Topics

Hyaluronic Acid

Regulatory T Cells

Toxoplasma Gondii

Top Venues

Molecular pharmaceutics

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Takashi Nakamura, Shun Sasaki, Yusuke Sato, Hideyoshi Harashima
Cancer Immunotherapy with Lipid Nanoparticles Loaded with a Stimulator of Interferon Genes Agonist against Renal Tumor Lung Metastasis. Pharmaceutics 16 (1) (2023)
Takashi Nakamura, Shun Sasaki, Yusuke Sato, Hideyoshi Harashima
Cancer Immunotherapy with Lipid Nanoparticles Loaded with a Stimulator of Interferon Genes Agonist against Renal Tumor Lung Metastasis. Pharmaceutics 16 (1) (2023)
Takashi Nakamura, Shun Sasaki, Yusuke Sato, Hideyoshi Harashima
Cancer Immunotherapy with Lipid Nanoparticles Loaded with a Stimulator of Interferon Genes Agonist against Renal Tumor Lung Metastasis. Pharmaceutics 16 (1) (2023)
Takashi Nakamura, Takanori Sato, Rikito Endo, Shun Sasaki, Naomichi Takahashi, Yusuke Sato, Mamoru Hyodo, Yoshihiro Hayakawa, Hideyoshi Harashima
STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation. Journal for immunotherapy of cancer 9 (7) (2022)
Nako Maishi, Yu Sakurai, Hiroto Hatakeyama, Yui Umeyama, Takashi Nakamura, Rikito Endo, Mohammad Towfik Alam, Cong Li, Dorcas Akuba-Muhyia Annan, Hiroshi Kikuchi, Hirofumi Morimoto, Masahiro Morimoto, Kosuke Akiyama, Noritaka Ohga, Yasuhiro Hida, Hideyoshi Harashima, Kyoko Hida
Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system. Cancer science 113 (5) (2022)
Takashi Nakamura, Minori Kawai, Yusuke Sato, Masatoshi Maeki, Manabu Tokeshi, Hideyoshi Harashima
The Effect of Size and Charge of Lipid Nanoparticles Prepared by Microfluidic Mixing on Their Lymph Node Transitivity and Distribution. Molecular pharmaceutics 17 (3) (2020)
Mio Maeta, Naoya Miura, Hiroki Tanaka, Takashi Nakamura, Ryo Kawanishi, Yoshifumi Nishikawa, Kenichi Asano, Masato Tanaka, Shinya Tamagawa, Yuta Nakai, Kota Tange, Hiroki Yoshioka, Hideyoshi Harashima, Hidetaka Akita
Vitamin E Scaffolds of pH-Responsive Lipid Nanoparticles as DNA Vaccines in Cancer and Protozoan Infection. Molecular pharmaceutics 17 (4) (2020)
Rikito Endo, Takashi Nakamura, Kyoko Kawakami, Yusuke Sato, Hideyoshi Harashima
The silencing of indoleamine 2,3-dioxygenase 1 (IDO1) in dendritic cells by siRNA-loaded lipid nanoparticles enhances cell-based cancer immunotherapy. Scientific reports 9 (1) (2019)
Hideyuki Masuda, Takashi Nakamura, Yosuke Noma, Hideyoshi Harashima
Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology. Molecular pharmaceutics 15 (12) (2018)
Takashi Nakamura, Koharu Yamada, Yuki Fujiwara, Yusuke Sato, Hideyoshi Harashima
Reducing the Cytotoxicity of Lipid Nanoparticles Associated with a Fusogenic Cationic Lipid in a Natural Killer Cell Line by Introducing a Polycation-Based siRNA Core. Molecular pharmaceutics 15 (6) (2018)